The Alzheimer’s Association — a Chicago-based nonprofit ... and greater opportunity to have more time. Having multiple treatmentoptions is the kind of advancement we’ve all been waiting ...
The Alzheimer’s Association — a Chicago-based nonprofit ... and greater opportunity to have more time. Having multiple treatmentoptions is the kind of advancement we’ve all been waiting ...
Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.
Blarcamesine is an orally once daily administered small molecule for the potential treatment of patients with Alzheimer’s disease. “The EMA filing acceptance for blarcamesine to review the ...
Some results have been hidden because they may be inaccessible to you